Are There Any Recent Advances in Research on TNFR1 in Cancer?
Recent research has focused on the development of more selective inhibitors and the use of combination therapies to modulate TNFR1 activity. Advances in gene editing technologies such as CRISPR-Cas9 have also enabled researchers to study the specific contributions of TNFR1 in various cancer types more precisely. Furthermore, insights into the tumor microenvironment and immune response have provided new avenues for targeting TNFR1 in cancer therapy.